Global Neurovascular Devices Market

Market Size

The global neurovascualr devices market, valued at USD 3,571 million in 2025, is projected to reach USD 3,882 million in 2026 and USD 7,011 million by 2035, with a 6.8% CAGR during the forecast period 2026 to 2035.

Market Report: Key Takeaways

Market Size & Trends

• In terms of type of device, the neurothrombectomy device segment holds the highest share (~50%) of the market.
• With regards to therapeutic application, the ischemic stroke segment dominates the global market with more than 45% market share.
• Based on the end user, the hospitals and specialty clinics hold the largest market share (nearly 70%) in 2025.
• In terms of geographical regions, North America captures the majority of the market share, and Middle East and North Africa is likely to grow at a faster pace in the near future.

Market Overview

It is worth highlighting that neurovascular disorders are recognized among the top five life-threatening disorders, accounting for significant economic burden across different geographical regions. According to World Health Organization, approximately 15 million new cases and five million mortalities worldwide, are caused by neurovascular disorders, annually. The key factors contributing to the pathogenesis and growing prevalence of neurovascular disorders include poor lifestyle, physical trauma, malnutrition, brain injury and congenital abnormalities.

Conventional surgical approaches used for the effective treatment of neurovascular disorders include open neurosurgery, microsurgery, craniotomy and bypass surgery. However, these approaches are not competent enough to treat the disease effectively. This is a result of their complex and time-consuming nature combined with a lower success rate, delayed recovery rate and requirement of expert supervision for performing such surgical operations.

In order to address these limitations associated with the existing surgical methods, neurovascular devices, such as intracranial stents, embolic coils, flow diverters, guidewires and catheters have emerged as a potential treatment option. Notably, these medical devices work by redirecting the blood flow disrupted at a specific region and present more precise and targeted results. Several technological advancements in the neurovascular devices and neurostimulation devices have led to consideration of these devices as a novel treatment option for treating neurovascular disorders. The market size for neurovascular devices will experience significant market growth over the forecast period because of the continuous research efforts, innovation and rising interest of investors in this domain.

Industry Experts on Global Neurovascular Devices Market

Players engaged in the neurovascular devices domain are continuously upgrading their portfolio. In 2025, Carsten Schroeder, (President and CEO, Terumo Neuro), states, “I would say that mechanical thrombectomy is still the fastest growing segment depending on how you look at it, it is more than double digits. Then, at the moment it is followed by hemorrhagic. The moment the embolics get approved for chronic subdural, I think we will see a massive creation of a market there.”

Neurovascular Devices Market Trends

• Rise in Partnership and Collaborations Activity: In recent years, several partnerships and collaborations have been established by neurovascular device developers. Such deals are forged to allow companies to expand their respective product portfolios in order to gain additional capabilities and increase visibility in this domain. It is worth highlighting that the partnerships signed in this industry have primarily been focused on the neurovascular catheters market, followed by the market for embolization devices. This can be attributed to the fact that catheters can be used alone or in conjunction with other neurovascular devices to facilitate the insertion and guidance of other devices, thus highly preferred for the treatment of wide-ranging neurovascular disorders. For instance, recently, Embolx partnered with Girlow in order to increase the distribution of their balloon occlusion microcatheters in Mexico, Central America, South America and the Caribbean.
• Significant Number of Acquisitions: including the acquisition of the US-based Pulse Technologies by Integer Holdings and Japan Medical Device Technology by Kaneka Neurovascular. We expect the neurovascular medical device companies to continue to form strategic alliance with other companies in order to expand their product portfolio, meet the customer demand and drive the market growth during the forecast period.
• Neurovascular Device Companies Have Experienced an Investment Growth in the Past Years: Over the years, monetary assistance from angel investors, venture capitalists, and funding schemes of various public and private organizations / funds, along with assistance from regulatory authorities, have allowed start-ups / small companies to progress their R&D efforts in the neurovascular devices industry. Notably, in the past five years, neurovascular device companies have raised a total amount worth around USD 1.5 billion for research and development activities in order to expand their product portfolio. Further, it is worth mentioning that most of the funding instances reported were venture capital rounds, followed by private placements.

Market Share Insights

Market Share by Therapeutic Application

• This segment highlights the distribution of the neurovascular devices market across different therapeutic applications, such as ischemic stroke, aneurysm, stenosis and arteriovenous malformations (AVMs).
• It is worth highlighting that the neurovascular devices for ischemic stroke holds the largest share (49%) in the current market. This can be attributed to the fact that ischemic strokes has the highest global incidence rate, accounting for around 3.3 million deaths, worldwide, each year.
• In the coming years, neurovascular devices used for aneurysm are anticipated to grow at a relatively faster pace (CAGR of 8.86%), owing to the growing demand for advanced devices to treat the complications associated with aneurysm treatment such as aneurysmal rupturing and severe bleeding.

Market Share by Type of Device

• The global market is segmented into different types of devices, such as neurothrombectomy devices, embolization devices and angioplasty devices.
• Among these devices, neurothrombectomy devices hold the maximum (51%) neurovascular devices market share. This can be attributed to the high incidence rate of ischemic strokes accounting for 62.4% of all stroke cases worldwide. As neurothrombectomy devices are used for the treatment of ischemic strokes, the technical advancements in their structural dimensions, such as integration of imaging technologies and are rapidly transforming the therapeutic management of ischemic stroke.
• Further, in the coming years, the embolization devices are anticipated to grow at a CAGR of 8.65%, owing to the advancements in interventional technology and increased awareness among healthcare providers about the benefits of embolization devices for the treatment of aneurysms, coupled with growing prevalence of various neurovascular disorders.

Key Market Insights

Advantages of Neurovascular Devices

Neurovascular devices have a wide range of advantages including their ability to provide site-specific treatments with lower surgical trauma and minimally invasive approaches for treating neurovascular disorders. Further, these neurovascular devices are manufactured under stringent regulatory guidelines in order to ensure the safety and efficacy of the device, thus ensuring positive healthcare outcomes.

Market Size Analysis: What is the Opportunity for Neurovascular Device Companies?

The global neurovascular devices market size is likely to be worth $ 3,571 million in 2025 and will reach $ 7,011 million by 2035. In terms of the type of device, neurothrombectomy devices segment holds the largest share of the market, being minimally invasive in nature. The market size for embolization devices is likely to grow at a relatively higher CAGR of ~9% during the forecast period.

The growing prevalence of neurovascular disorders and favorable reimbursement policies for the use of neurovascular devices and procedures are the primary drivers of this market. Further, the limited side effects of these devices also serve as a key driver for the growth of this market.

What are the Key Drivers of Global Neurovascular Devices Market?

The increasing incidence of neurovascular disorders is a major driver for the increasing adoption of neurovascular devices. According to Centers for Disease Control and Prevention , around 3.1% of the adult population of the US experience brain stroke each year. According to World Health Organization, approximately 15 million new cases and five million mortalities worldwide, are caused by neurovascular disorders, annually. The key factors contributing to the pathogenesis and growing prevalence of neurovascular disorders include poor lifestyle, physical trauma, malnutrition, brain injury and congenital abnormalities.

Further, conventional methods (including open neurosurgery, microsurgery, craniotomy and bypass surgery) have often presented surgical complications, such as disruption of normal vasculature and longer recovery periods, leading to an increased adoption of innovative neuro interventional techniques and procedures.

Furthermore, over the past few years, various stakeholders have forged several alliances with players in this domain to develop modern neurovascular devices with the latest technology due to the rising demand for neurovascular devices. This will propel the growth of this industry.

Market Segmentation Insights

Key Report Attributes

Frequently Asked Questions